Meta-analysis of 24 trials (2010–2021): heart rate variability biofeedback significantly reduces stress and anxiety, with moderate-to-strong effect sizes maintained in the short term.
This meta-analysis by Yu et al. (2022), published in Applied Psychophysiology and Biofeedback (DOI 10.1007/s10484-021-09564-0), analyzes 24 scientific trials conducted between 2010 and 2021 on the efficacy of heart rate variability biofeedback (HRV biofeedback) for reducing stress and anxiety in varied populations.
HRV biofeedback is a technique in which the patient learns to regulate breathing at a precise frequency (generally 0.1 Hz, or 6 breaths/minute) to maximize heart rate variability, a direct indicator of sympathovagal balance and resilience to stress.
The meta-analysis includes diverse populations: professionals under chronic stress, patients with generalized anxiety disorder, athletes, students and patients with stress-dependent somatic conditions.
Controlled trials using real-time HRV feedback. Adult populations with measurable stress or anxiety. Protocols of at least 4 sessions. Standardized, psychometrically validated measures (PSS, STAI, BAI, HAM-A).
Protocol durations: 4 to 12 weeks. Frequency: 1 to 3 sessions/week. Session length: 20 to 40 min. Breathing-guided biofeedback (cardiac coherence) coupled with real-time visual or auditory feedback of HRV.
Perceived stress: PSS-10, PSS-14. Anxiety: STAI (state and trait), BAI, HAM-A. Biomarkers: RMSSD, LF/HF power, salivary cortisol. Cardiovascular parameters: resting blood pressure, heart rate.
Random effects model. Hedges g effect size. Heterogeneity assessed by I² and Cochran's Q test. Subgroup analysis by population type, protocol and outcome. Publication bias assessed by funnel plot.
An effect size of g = 0.81 on the reduction of perceived stress is scientifically exceptional. For comparison, first-line anxiolytics (benzodiazepines) show similar effect sizes on acute anxiety, but with major risks of tolerance and dependence. HRV biofeedback offers a comparable effect, without side effects and with transferable learning.
What is fundamental in our practice is that HRV biofeedback does not mask stress, it trains the autonomic nervous system to regulate the stress response more effectively. Our patients learn a physiological skill that belongs to them: they can activate cardiac coherence at will, in 90 seconds, without any equipment once training is complete.
The reduction of -14 mmHg in systolic blood pressure in hypertensive subgroups opens an important scientific application for patients with cardiovascular risk, as a complement or preventive to drug treatment.
Our HRV biofeedback sessions last 30 to 40 minutes and include real-time visual feedback of cardiac coherence, learning of breathing at a personalized resonance frequency, and progress monitoring through continuous RMSSD tracking.